MedTrace Logo

Research Protocol On Developing an Integrated Technology-Moderated Institutional Health Promotion Model

NCT03030534 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2021-10-25

No results posted yet for this study

Summary

The purpose of this study is to adopt an operational research approach that seeks to design, develop and pilot-test the health-promotion lifestyle model that will enhance health-promoting behaviour and lifestyle modification of university staff in Nigeria. The following are the hypotheses of the study:

1. There will be a significant difference in the pre and post intervention practices of health promoting lifestyle behaviours (behaviour specific cognition and affect) of NOUN staff
2. There will be significant association between the health promoting lifestyle behaviours (behavioural outcome) and health status of NOUN staff
3. There will be a significant difference in the pre-and post-intervention health promoting lifestyle behaviours (behavioural outcome) of staff of NOUN
4. There will be a significant difference in the pre-and post-intervention health status measure (specific health measurement indicators) of staff of NOUN

Conditions

  • Health Behavior

Interventions

COMBINATION_PRODUCT

Educational package and software package

Using Information and communication technology to deliver health promoting activities

OTHER

Health promotion tips

Give general information on health promotion

Sponsors & Collaborators

  • University of KwaZulu

    lead OTHER

Principal Investigators

  • Elizabeth M Joseph-Shehu, MSc · University of KwaZulu-Natal, Durban, South Africa

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2018-04-09
Completion
2018-04-09

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03030534 on ClinicalTrials.gov